ReviewHeart failure reviews2021

Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors.

Davide Margonato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.